Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2005) 9 P132

BES2005 Poster Presentations Steroids (17 abstracts)

Immunomodulatory 1,25dihydroxyvitamin D3 synthesis by dendritic cells and macrophages is highly dependent on the availability of inactive substrate 25D3 levels

KN Evans 1 , F Burke 2 , SV Hughes 1 , L Freeman 3 , DM Sansom 2 & M Hewison 1


1Division of Medical Sciences, Institute of Biomedical Research (IBR), Medical School, The University of Birmingham, Birmingham, UK, 2Division of Immunity and Infection, MRC centre for immune regulation, Institute of Biomedical Research (IBR), Medical School, The University of Birmingham, Birmingham, UK, 3Institute of Cancer Studies, The University of Birmingham, Vincent Drive, Edgbaston, Birmingham, UK,


Recently, evidence has emerged that active 1,25dihydroxyvitamin D3 (1,25D3) is involved in modulating the immune response. Additionally, vitamin D3 insufficiency has been proposed as a predisposing factor for autoimmune diseases, which correlate with circulating inactive 25-hydroxyvitamin D3 (25D3). Substrate 25D3 is converted to 1,25D3 by the activating enzyme 1alpha-hydroxylase. We and others have previously shown that during DC differentiation from circulating monocyte precursors, DCs upregulate 1alpha-hydroxylase and have an increased capacity to produce 1,25D3. Conversely, we previously demonstrated that increased capacity to produce 1,25D3 coincides with downregulation of VDR expression. This implies 1,25D3 produced locally by mature DCs may signal in a paracrine fashion to regulate or inhibit development of circulating monocyte precursors which express abundant VDR. Here we extend these observations and demonstrate that macrophages and DCs show similar 1alpha-hydroxylase kinetics. To assess the functional significance of circulating 25D3 levels we cultured DCs and macrophages from monocyte precursors under conditions that mimic vitamin D3 deficiency, insufficiency and sufficiency. Cells were cultured with 5% human serum alone or with 50 or 150 nM 25D3 added during culture in the presence or absence of ketoconazole (1alpha-hydroxylase inhibitor). Analysis of supernatants by radioimmunoassay showed dose-dependent accumulation of active 1,25D3 in DCs and macrophages which was inhibited by ketoconazole. In parallel, increasing doses of 1,25D3 and 25D3 resulted in lower expression of the antigen presenting MHC class II and co-stimulatory molecules. Conversely, 25D3 and 1,25D3 enhanced expression of the monocyte marker CD14. Responses to 25D3 but not 1,25D3 were blocked by ketoconazole. Together, data suggest local synthesis of 1,25D3 may have immunomodulatory effects on DC and macrophage phenotype, furthermore the ability of macrophages and DCs to synthesise 1,25D3 is highly dependent on substrate 25D3 levels, which maybe a pivotal factor in mediating the impact of vitamin D3 deficiency and insufficiency on autoimmune disease.

Volume 9

24th Joint Meeting of the British Endocrine Societies

British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.